Phytosterolemia with thrombocytopenia as the first clinical manifestation: a case report and literature review
-
Abstract: Phytosterolemia known as β-sitosterolemia is a rare autosomal recessive lipid storage disease, which is caused by mutations of ABCG5 and ABCG8 genes. Its clinical manifestations are extremely heterogeneous, result in a high misdiagnosis rate. The common clinical manifestations are tendinous and cutaneous xanthomas, arthritis, premature cardiovascular disease and atherosclerosis. Patients with hematologic abnormalities as the first clinical manifestation are rare. We reported a 53-year-old female patient with thrombocytopenia as the first clinical manifestation. Large platelets, spherocytes and stomatocytes were found on the peripheral blood smear. The homozygous variants were detected in exon 6(c.G788A) of ABCG8 by next generation sequencing. We discuss the clinical manifestations, pathogenesis and treatment of this disease. For patients with unexplained hemolytic anemia, macrothrombocytopenia and splenomegaly, the possibility of this disease should be considered.
-
Key words:
- phytosterolemia /
- thrombocytopenia /
- ABCG5 /
- ABCG8
-
[1] Bastida JM, Girós ML, Benito R, et al. Sitosterolemia: diagnosis, metabolic and hematological abnormalities, cardiovascular disease and management[J]. Curr Med Chem, 2019, 26(37): 6766-6775. doi: 10.2174/0929867325666180705145900
[2] Wang H, Liu Min, Portincasa P, et al. Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease[J]. Adv Exp Med Bio, 2020, 1276: 105-136.
[3] Bastida JM, Benito R, González-Porraset JR, et al. ABCG5 and ABCG8 gene variations associated with sitosterolemia and platelet dysfunction[J]. Platelets, 2021, 32(4): 573-577. doi: 10.1080/09537104.2020.1779926
[4] 曹丽娟, 余自强, 江森, 等. 伴有血液学异常的植物固醇血症20例临床特征分析[J]. 中华医学杂志, 2019, 99(16): 1226-1231. doi: 10.3760/cma.j.issn.0376-2491.2019.16.007
[5] Zhang J, Ma J, Wu RH, et al. Unusual presentations of sitosterolemia limited to hematological abnormalities: A report of four cases presenting with stomatocytic anemia and thrombocytopenia with macrothrombocytes[J]. Am J Hematol, 2019, 94(5): E124-E127.
[6] 孙翰, 黄璨, 李源杰, 等. 第462例血两系减低-关节痛-肝功异常-植物固醇血症[J]. 中华医学杂志, 2019, 99(16): 1267-1270. doi: 10.3760/cma.j.issn.0376-2491.2019.16.015
[7] 曹科, 罗小娟, 刘景, 等. 3例植物固醇血症患儿临床表型、实验室检查、基因诊断及文献复习[J]. 临床检验杂志, 2019, 37(6): 461-466. https://www.cnki.com.cn/Article/CJFDTOTAL-LCJY201906015.htm
[8] 王改锋, 王兆钺, 曹丽娟, 等. 表现为巨大血小板减少与溶血性贫血的植物固醇血症1例并文献复习[J]. 临床血液学杂志, 2013, 26(11): 758-761. http://lcxz.cbpt.cnki.net/WKC/WebPublication/paperDigest.aspx?paperID=28927e35-83d8-4115-a7aa-0ccd35cad811
[9] Wang Z, Cao L, Su Y, et al. Specific macrothrombocytopenia/hemolytic anemia ass ociated with sitosterolemia[J]. Am J Hematol, 2014, 89(3): 320-324. doi: 10.1002/ajh.23619
[10] Neff AT. Sitosterolemia's stomatocytosis and macrothrombocytopenia[J]. Blood, 2012, 120(22): 4283. doi: 10.1182/blood-2012-06-429449
[11] Nomura A, Tada H, Nohara A, et al. Oral Fat Tolerance Test for Sitosterolemia and Familial Hypercholesterolemia: A Study Protocol[J]. J Atheroscler Thromb, 2018, 25(8): 741-746. doi: 10.5551/jat.42960
[12] Yoo EG. Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management[J]. Ann Pediatr Endocrinol Metab, 2016, 21(1): 7-14. doi: 10.6065/apem.2016.21.1.7
[13] 房迪, 梁黎黎, 邱文娟, 等. 谷固醇血症三例的临床、基因分析及治疗效果[J]. 中华儿科杂志, 2018, 56(6): 435-439. doi: 10.3760/cma.j.issn.0578-1310.2018.06.006
[14] 叶文灿. 一例植物固醇血症家系、遗传学研究并文献复习[D]. 南昌: 南昌大学, 2020.
[15] Chase TH, Lyons BL, Bronson RT, et al. The mouse mutation "thrombocytopenia and cardiomyopathy"(trac)disrupts Abcg5: a spontaneous single gene model for human hereditary phytosterolemia/sitosterolemia[J]. Blood, 2010, 115(6): 1267-1276. doi: 10.1182/blood-2009-05-219808
[16] Mekchay P, Ittiwut C, Ittiwut R, et al. Whole exome sequencing for diagnosis of hereditary thrombocytopenia[J]. Medicine(Baltimore), 2020, 99(47): e23275.
[17] Kanaji T, Kanaji S, Montgomery RR, et al. Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia[J]. Blood, 2013, 122(15): 2732-2742. doi: 10.1182/blood-2013-06-510461
[18] Parsons HG, Jamal R, Baylis B, et al. A marked and sustained reduction in LDL sterols by diet and cholestyramine in betasitosterolemia[J]. Clin Invest Med, 1995, 18(5): 389-400.
[19] Lutjohann D, Bergmann K, Sirah W, et al. Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study[J]. Int J Clin Pract, 2008, 62(10): 1499-1510. doi: 10.1111/j.1742-1241.2008.01841.x
[20] Salen G, Bergmann K, Lütjohann D, et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia[J]. Circulation, 2004, 109(8): 966-971. doi: 10.1161/01.CIR.0000116766.31036.03
[21] Othman RA, Myrie SB, Mymin D, et al. Ezetimibe reduces plant sterol accumulation and favorably increases platelet count in sitosterolemia[J]. J Pediatr, 2015, 166(1): 125-131. doi: 10.1016/j.jpeds.2014.08.069